CLINICAL_TRIALS
trial_result
· 2018-03-12
Clinical Trial Update: A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor [Phase 2]
Summary
A Phase 2 clinical trial evaluating sunitinib in young patients with advanced gastrointestinal stromal tumors has completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: COMPLETED | Results posted: 2018-03-12